Psychiatric morbidity in psoriasis: a study in Himachal Pradesh, India

Kashyap, Subhash; Kumar, Ajay; Kumar, Ramesh; Shanker, Vinay

doi:10.18203/2320-6012.ijrms20161872

Cited by 3 publications

(5 citation statements)

References 17 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Anxiety disorders have been reported in various studies where, adjustment disorders range from 15-62%. 6,18 In our study, 3.8% were diagnosed with adjustment disorders, which is similar to a study reported from Himachal Pradesh, 34 where 2.4% of patients were diagnosed with adjustment disorders. Generalized Anxiety Disorder (GAD) was reported to be 9-13% in various studies.…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Study of Psychiatric Disorders in Patients with Psoriasis attending Outpatient Department in a Tertiary Hospital

2021

View full text Add to dashboard Cite

The neuro-immuno-cutaneous endocrine model explains the mind-body connection. This model explains how many inflammatory dermatoses are triggered or exacerbated by stress factors. These conditions are called psychophysiological skin diseases. Psoriasis is a common psychophysiological skin disease. It affects 2-4% of the population worldwide and involves multiple systems in the body. The rates of psychiatric comorbidities are high in psoriasis, but still, they are not given due attention which leads to an increase in morbidity and mortality in the long run. This study intends to uncover the psychiatric comorbidities in psoriasis patients. In this study, the prevalence of psychiatric disorders was investigated among 104 patients with psoriasis. Following rating scales were used; Hamilton rating scales for depression and anxiety, Presumptive stressful life event scale, Beck scale for suicidal ideation, and Dermatology life quality index. The prevalence of psychiatric disorders in Psoriasis patients was found to be 66.35%. Among the psychiatric disorders, 29.8 % were dependent on substances, 18.27% were found to be suffering from depression,15.38 % with anxiety disorder and 2.88 % with psychotic disorders. Psoriasis has a high prevalence of psychiatric morbidity.

show abstract

Section: Discussionsupporting

confidence: 89%

“…Obssessive Compulsive Disorder (OCD) and Social phobia were seen in 1.0% each in this study. Social phobia was reported to be seen in 1.6% of patients by Kashyap et al 34 The difference in results could be due to the different populations under study, different methods of reporting used, or under-reporting of symptoms by the patients.…”

Section: Discussionmentioning

confidence: 92%

Study of Psychiatric Disorders in Patients with Psoriasis attending Outpatient Department in a Tertiary Hospital

2021

View full text Add to dashboard Cite

show abstract

“…In this study, 61% of psoriasis patients had psychiatric morbidities, whereas 39% had none. This result was comparable to that of Singh et al [ 13 ] in 2016, Kashyap et al [ 13 ] in 2016, and Paradesi et al [ 11 ] in 2019, who reported psychiatric morbidity rates of 47%, 48%, and 74% in psoriasis patients, respectively. In our study, it was evident that the most common psychiatric morbidity associated with psoriasis was depressive episode (51.51%) followed by anxiety disorder, unspecified (24.24%) and social phobia (9.09%), which was consistent with the existing literature.…”

Section: Discussionsupporting

confidence: 88%

“…The majority of the patients in this study were 31-40 years of age, male, married, from urban domiciles, from the upper-lower socioeconomic scale as classified by the Kuppuswamy scale updated for the year 2019, from lower educational backgrounds and belonged to a joint family. The demographics are similar to other studies [11][12][13][14][15][16][17][18][19][20].…”

Section: Discussionsupporting

confidence: 85%

Psychiatric Morbidities and Their Impact on Quality of Life in Patients With Psoriasis

Kumar¹,

Bhuyan²,

Barua³

et al. 2023

Cureus

View full text Add to dashboard Cite

Background Psychiatric morbidities, which are commonly seen in psoriasis patients, are often missed or ignored leading to poor quality of life. A lack of communication between psychiatrists and dermatologists leads to ignorance of psychiatric morbidities in psoriasis patients, which can eventually take a severe form. Therefore, both groups must collaborate to provide high-quality patient care. As there is a dearth of such studies in the North-Eastern part of India, this study aimed to highlight the above-mentioned problem. Aim The aim of this study was to study psychiatric morbidities in patients with psoriasis and to compare quality of life in psoriasis patients with and without psychiatric morbidities. Methods This study was a hospital-based cross-sectional study conducted in the Dermatology Department, Assam Medical College and Hospital, Dibrugarh, Assam, India from July 2020 to July 2021. Ninety patients with psoriasis were included in the study and the diagnosis was confirmed by a consultant dermatologist, then the Mini International Neuro-psychiatric Interview Scale (M.I.N.I.; version 5.0) scale was applied to screen psychiatric morbidities. The diagnoses were confirmed using ICD-10 followed by dividing psoriasis patients into two groups, i.e. with and without psychiatric morbidities. After that the World Health Organization Quality of Life (WHOQOL) scale was applied to both groups and the domains of quality of life were compared. Results Our results showed that 61.1% of psoriatic patients had psychiatric morbidities, which is abnormally high compared to other dermatological disorders. The psychological domain of quality of life was the most affected (WHOQOL scale scoring of 38.12±6.67 vs. 48.76±6.21) in both groups of patients (i.e., with and without psychiatric morbidities), and the environmental domain was the least affected (56.67±10.65 vs. 64.67±8.18). Every domain of quality of life had a lower score in patients with psoriasis with psychiatric morbidities as compared to those without ( p <0.05). Conclusion Our results of 61.1% psychiatric morbidities in psoriasis patients emphasize the need for psychiatric evaluation in every psoriasis patient. The timely intervention of psychiatric morbidity in psoriasis patients with collaboration of psychiatrists and dermatologists will surely improve the patient’s condition to some extent and, thus, their quality of life.

show abstract

“…25 The age and gender profile of pa-tients in present study was similar to that reported by Kashyap et al who conducted their study in 125 psoriasis patients with mean age 39.92 years, of which 78 (62.4%) were males. 26 Dimitrov et al too conducted their study in a male-dominated psoriasis patient population (60.2%) who had a mean age of 36.6 years. 27 In present study, we found moderate to severe restriction of social participation in 24.1% and 27.1% patients.…”

Section: Discussionmentioning

confidence: 99%

A clinical study to assess disability and stigma associated with psoriasis

et al. 2021

View full text Add to dashboard Cite

Background: Psoriasis relatively common, chronic, inflammatory and hyper-proliferative skin disease that affects 1.4% to 2.0 % of the population. Pateints with psoriasis have to face severe problems with stigmatization, discrimination and negative attitudes in general among the public, and often bear the brunt of public rejection.Methods: A cross-sectional observational study was carried out on psoriasis patients attending dermatology outpatient department of Era’s Lucknow medical college and hospital between November 2018 and November 2020. Patients with pustular psoriasis, mycosis fungoides, pityriasis rubra pilaris, and other severe medical conditions like heart failure, liver cirrhosis were excluded from the study.Results: Present study included 170 (aged 16 to 76 years; mean age 37.74±13.70 years; 62.4% males) clinically diagnosed patients of Psoriasis. P-score was observed with increase in Body Surface area, maximum for cases with BSA ≥25%. There was a strong positive significant linear correlation between stigmatization scores and disability scores (r=0.746; p<0.001), thus indicating that with increase in p scores there was a significant increase in PDI scores and vice versa.Conclusions: Present study showed that feeling of stigmatization and disability was highly prevalent in psoriasis patients. It was seen that stigmatization and disability showed a strong correlation. The findings of study showed that there is need to create awareness regarding psoriasis as a non-communicable disease in order to increase the acceptance of psoriasis patients in society and to reduce their stigmatization.

show abstract

Psychiatric morbidity in psoriasis: a study in Himachal Pradesh, India

Cited by 3 publications

References 17 publications

Study of Psychiatric Disorders in Patients with Psoriasis attending Outpatient Department in a Tertiary Hospital

Study of Psychiatric Disorders in Patients with Psoriasis attending Outpatient Department in a Tertiary Hospital

Psychiatric Morbidities and Their Impact on Quality of Life in Patients With Psoriasis

A clinical study to assess disability and stigma associated with psoriasis

Contact Info

Product

Resources

About